Calls & outcomes

From thesis
to outcome.

Below is a selection of calls we made through our research and how those views ultimately played out. We update this page as our theses evolve and new calls reach their conclusion.

2026
  • Jul 2026 Called the KOSPI top With breadth collapsing, foreign investors exiting, and leveraged retail absorbing the selling, we warned of a sharp reversal. The exact timing was pure luck: we published at the top before the KOSPI fell 30% in July. Our analysis was cited by Bloomberg, The Wall Street Journal, and many South Korean media outlets.
  • Jun 2026 Short the euro We shorted EUR/USD near 1.15 as yield spreads and diverging Fed and ECB policy favored the dollar. The trade initially moved against us, but positive carry paid us to hold. EUR/USD fell to 1.11 by September.
  • Jun 2026 Long aluminum over gold We favored aluminum’s constrained supply and electrification exposure over gold, which faced rising real yields. Both metals declined over the following months, and the relative trade failed to deliver.
  • Jun 2026 Long oil After Brent fell from $110 to $70, we argued markets were too complacent about the Middle East war and underestimated persistent supply constraints. Oil returned to the $100 to $110 range over the following months.
  • May 2026 Long Chinese internet platforms Alongside our bullish turn on US software, we initiated a position in Chinese platforms, expecting Alibaba, Tencent, and Baidu to catch up with the hardware-led ChiNext. The trade failed as China’s weak macro backdrop pressured earnings, and we closed at a 10% loss.
  • May 2026 Turned bullish on software After our January bearish call preceded a decline of more than 20%, we reversed in May as the selloff became indiscriminate and usage-based models emerged as AI beneficiaries. The software sector climbed 20% over the next three months.
  • Apr 2026 US curve steepener Alongside our short duration positioning, we expected the Fed to look through the oil shock while term premium lifted long yields. Instead, the Fed reversed course and began a brief tightening cycle, flattening the curve.
  • Apr 2026 Overweight EM equities We argued the EM rotation would survive the Middle East war, supported by stronger earnings, attractive valuations, and real asset exposure. EM gained 23% through June versus 15% for US equities, before South Korea’s sharp decline left relative outperformance subdued thereafter.
  • Apr 2026 Long the yuan through CGBs The Middle East war was another catalyst for yuan outperformance, as China’s commodity reserves and renewable capacity insulated it from the oil shock. We expressed the view by overweighting CGBs. The yuan appreciated 3% against the dollar over the next six months.
  • Apr 2026 Long corn With urea up 60% while corn barely moved, we argued the fertilizer shock would reach corn with a lag. Fertilizer retreated in May, but corn climbed 20% in August, consistent with our thesis, though its impact cannot be isolated from other catalysts.
  • Apr 2026 Long NOK over CAD With both currencies treated as oil proxies, we favored the cheaper NOK for its stronger sovereign backing and greater leverage to elevated oil. NOK/CAD moved 4% in our favor. We closed in June as oil normalized and the thesis’s main driver faded.
  • Mar 2026 The bull market will continue despite the Iran war We argued the war would not end the bull market: the expansion remained solid, oil was below growth-damaging levels, and financial conditions were accommodative. The bull market held, and the AI trade resumed once the dust settled.
  • Mar 2026 Long GBP over EUR As an LNG shock sent European gas prices surging, we expected the UK’s greater gas sensitivity to keep the BoE slower to cut than the ECB. GBP/EUR rose from 1.145 to 1.18 by July 2026.
  • Mar 2026 Long USD When the Iran conflict closed Hormuz and sent crude higher, we argued the supply shock would give the dollar both a safe-haven bid and a net-energy-exporter advantage. The dollar index rose more than 3% over the four months to June.
  • Feb 2026 Long China AI We saw H200 approval as a catalyst for China to close the AI gap and stayed long Nvidia and Chinese AI. Open-weight models reached roughly 30% of global usage. Nvidia gained over 25% in three months and Zhipu over 600%.
  • Feb 2026 Short the yen We saw the yen rally and Plaza Accord talk as a positioning reset, not a regime change, as Japan’s fiscal and term-premium dynamics dominated rate differentials. USD/JPY rose from 155 to 163, a 40-year high. Bloomberg later cited our analysis.
  • Jan 2026 Overweight gold and broader commodities We carried our early-2025 gold overweight into 2026 on fiscal deterioration and returning inflation while adding broader commodities. Gold suffered a double-digit drawdown as the Iran shock lifted real yields and the dollar; aluminium gained 14% and copper 4%.
  • Jan 2026 Overweight international equities, led by ex-US tech We called a regime shift away from US leadership, favoring cheaper international equities, especially AI-adjacent technology. Over the next five months, Korea returned 47%, Taiwan 26%, and Japan 13%, each outperforming the US.
  • Jan 2026 SaaS underperformance to continue We argued agentic AI was breaking the per-seat model and that SaaS would keep underperforming, with only select names such as Datadog outperforming. The sector fell more than 20% over the following months even as the Nasdaq rose.
  • Jan 2026 Favor oil consumers over producers With the IEA projecting a record 4m b/d surplus, we expected lower oil and favored consumers over producers. Our flagged Hormuz risk then materialized, sending crude and producers higher while consumers sold off.
  • Jan 2026 Overweight data-center and electrification names With manufacturing in its longest contraction in decades, we avoided industrials broadly and favored AI data-center and electrification leaders. Over the next six months, Vertiv gained 80% and GE Vernova 60%, versus roughly 10% for S&P 500 Industrials.
  • Jan 2026 Inflation re-acceleration ahead While consensus expected a smooth return to 2%, distorted housing data and rising industrial commodities pointed to renewed price pressures. CPI rose from 2.4% to 4.2% by May 2026, though the oil shock amplified the move.
2025
  • Dec 2025 Long chinese biotech Big Pharma’s $314bn patent cliff made Chinese molecule licensing structural, but our call came late. After gaining another 10%, the index reversed and we exited down roughly 10%.
  • Dec 2025 Short long-duration Long-end yields were rising on an exploding term premium, and we stayed short long-duration Treasuries into sticky inflation. Over the five months to May 2026, the 10-year rose from 4.1% to 4.6% and the 30-year from 4.8% to 5.1%.
  • Nov 2025 Alphabet over Nvidia as TPUs gain ground Our view was that the AI-chip market would broaden beyond Nvidia (Google’s TPUs winning real traction with big buyers like Meta and Anthropic) and that Alphabet was the cleaner way to own the shift. Alphabet rose 34% over the six months that followed, against 23% for Nvidia.
  • Nov 2025 Power, not just chips, is the AI trade We argued electricity was the binding constraint on AI, and that the overlooked play was the power and grid complex. Over the seven months to June 2026, the S&P Global Clean Energy Transition Index rose 23%, beating Nvidia’s 8% though lagging the broader semiconductor index.
  • Nov 2025 Turned cautious on Bitcoin near $100,000 With Bitcoin near $100,000, we flagged a demand problem behind the bullish ETF and regulatory headlines (building outflows, the collapsed MicroStrategy premium, a broken altcoin complex) and called it a top. Within six months it had fallen roughly 40%.
  • Jan 2025 Frontier-tech baskets: AI, space, and humanoid robotics Our thematic research launched three frontier-tech baskets (AI, space, and humanoid robotics) on the view that each would reshape markets and economies in the years ahead. All three have since posted strong gains and meaningfully outperformed broad equities.

Start a trial

Available to professional investors only. See the research, test the access, then decide.

Request a trial →